Aktie GVBL6 GENOMIC VALLEY BIOTECH LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Genomic Valley Biotech Limited

Aktien

GVBL6

INE574D01010

GVBL6

Verzögert Bombay S.E.
Andere Börsenplätze
 08:02:51 05.07.2024 		% 5 Tage % 1. Jan.
47.6 INR -4.93% Intraday Chart für Genomic Valley Biotech Limited -22.20% +27.14%
09.05. Genomic Valley Biotech Limited berichtet über die Ergebnisse für das vierte Quartal und das Gesamtjahr zum 31. März 2024 CI
14.02. Genomic Valley Biotech Limited gibt die Ernennung von Frau Parul Agrawal als zusätzliches nicht-exekutives (nicht-unabhängiges) Mitglied des Verwaltungsrats mit Wirkung vom 14. Februar 2024 bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024
Genomic Valley Biotech Limited Announces Change in Corporate Office Address
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Genomic Valley Biotech Limited Announces Resignation of Mrs. Jyoti Bansal as Non-Executive (Independent) Director of the Company Effective December 14, 2023
Genomic Valley Biotech Limited Announces Resignation of Parul Agrawal as Non-Executive (Non-Independent) Director and Reconstitution of Committees
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Genomic Valley Biotech Limited Announces Executive Changes
Genomic Valley Biotech Limited Approves Shifting of Registered Office
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer
Genomic Valley Biotech Limited Announces Executive Changes
Genomic Valley Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Genomic Valley Biotech CFO Steps Down
Genomic Valley Biotech Limited Announces CFO Changes
Genomic Valley Biotech Limited Announces Change in Directorate
Genomic Valley Biotech Limited Announces Resignation of Mr. Pritam as Company Secretary / Compliance Officer
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Genomic Valley Biotech Limited Announces Appointment of Mr. Pritam as Company Secretary and Compliance Officer
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. GVBL6 Aktie
  4. Nachrichten Genomic Valley Biotech Limited
  5. Andere Sprachen